Applies to benralizumab: parenteral injection.
Side effects include:
Common adverse effects (≥5%): headache, pharyngitis.
For Healthcare Professionals
Applies to benralizumab: subcutaneous solution.
Frequency not reported: Anaphylaxis, angioedema[Ref]
Frequency not reported: Immunogenicity[Ref]
Common (1% to 10%): Injection site reactions (e.g., pain, erythema, pruritus, papule)[Ref]
Common (1% to 10%): Pharyngitis (bacterial, viral, or streptococcal), cough[Ref]
Common (1% to 10%): Pyrexia[Ref]
Common (1% to 10%): Headache[Ref]
Common (1% to 10%): Urticaria, rash[Ref]